View in EDS

MO-IPS suppresses acute myeloid leukemia through metabolic reprogramming and synergizes with anti-PD-1 immunotherapy.

Saved in:
Bibliographic Details
Title: MO-IPS suppresses acute myeloid leukemia through metabolic reprogramming and synergizes with anti-PD-1 immunotherapy.
Authors: Wang Y; Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu, 730000, China., Zhao W; Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu, 730000, China.; The First Clinical Medical School of Lanzhou University, Lanzhou, 730000, Gansu, China., Jin Y; Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu, 730000, China., Hu C; Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu, 730000, China.; The First Clinical Medical School of Lanzhou University, Lanzhou, 730000, Gansu, China., Fang X; Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu, 730000, China., Dong S; Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu, 730000, China. dongshh@lzu.edu.cn., Zhang B; Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu, 730000, China. zhangbl@lzu.edu.cn.
Source: Functional & integrative genomics [Funct Integr Genomics] 2026 Jun 17; Vol. 26 (1). Date of Electronic Publication: 2026 Jun 17.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: Germany NLM ID: 100939343 Publication Model: Electronic Cited Medium: Internet ISSN: 1438-7948 (Electronic) Linking ISSN: 1438793X NLM ISO Abbreviation: Funct Integr Genomics Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1438-7948
DOI:10.1007/s10142-026-01943-8